DK1677806T3 - Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre - Google Patents

Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre

Info

Publication number
DK1677806T3
DK1677806T3 DK04761743T DK04761743T DK1677806T3 DK 1677806 T3 DK1677806 T3 DK 1677806T3 DK 04761743 T DK04761743 T DK 04761743T DK 04761743 T DK04761743 T DK 04761743T DK 1677806 T3 DK1677806 T3 DK 1677806T3
Authority
DK
Denmark
Prior art keywords
treatment
sprains
congestion
stretching
acute
Prior art date
Application number
DK04761743T
Other languages
English (en)
Inventor
Robert John Petrella
Original Assignee
Robert John Petrella
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert John Petrella filed Critical Robert John Petrella
Application granted granted Critical
Publication of DK1677806T3 publication Critical patent/DK1677806T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04761743T 2003-10-09 2004-08-27 Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre DK1677806T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51068403P 2003-10-09 2003-10-09
PCT/CA2004/001579 WO2005032562A1 (en) 2003-10-09 2004-08-27 Methods for treating acute and overuse sprain and strain using hyaluronic acid

Publications (1)

Publication Number Publication Date
DK1677806T3 true DK1677806T3 (da) 2009-02-23

Family

ID=34421822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04761743T DK1677806T3 (da) 2003-10-09 2004-08-27 Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre

Country Status (14)

Country Link
US (1) US20050080037A1 (da)
EP (1) EP1677806B1 (da)
JP (4) JP2007507431A (da)
CN (1) CN1859918B (da)
AT (1) ATE414522T1 (da)
AU (1) AU2004277290B2 (da)
CA (1) CA2541813C (da)
DE (1) DE602004017888D1 (da)
DK (1) DK1677806T3 (da)
ES (1) ES2317018T3 (da)
PL (1) PL1677806T3 (da)
PT (1) PT1677806E (da)
SI (1) SI1677806T1 (da)
WO (2) WO2005032562A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2664334T3 (da) * 2004-12-30 2015-03-23 Genzyme Corp Regimer til intra-artikulær viscosupplementering
EP1968614A2 (en) * 2005-12-14 2008-09-17 Anika Therapeutics Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
ES2332667T3 (es) * 2006-05-11 2010-02-10 Sandra Gobbo Mezclas binarias de acido hialuronico y uso terapeutico de las mismas.
CA2749034C (en) * 2009-01-07 2019-01-15 Robert John Petrella Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
ES2665254T3 (es) 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
AU2013374192B2 (en) 2013-01-17 2018-11-08 Damian NAQVI Increasing muscular volume in a human using hyaluronic acid
CN106860706A (zh) * 2015-12-10 2017-06-20 仲伟波 双液删刺药液
RU2018141386A (ru) 2016-04-27 2020-05-27 Аника Терапьютикс, Инк. Композиция для применения в лечении дегенерации сухожилий

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
ATE525076T1 (de) * 2002-10-16 2011-10-15 Arthrodynamic Technologies Animal Health Division Inc Behandlung von traumatischer synovitis und geschädigtem gelenkknorpel

Also Published As

Publication number Publication date
CA2541813A1 (en) 2005-04-14
CN1859918A (zh) 2006-11-08
ATE414522T1 (de) 2008-12-15
US20050080037A1 (en) 2005-04-14
EP1677806B1 (en) 2008-11-19
WO2005034965A1 (en) 2005-04-21
ES2317018T3 (es) 2009-04-16
JP2014205721A (ja) 2014-10-30
EP1677806A4 (en) 2007-04-04
PT1677806E (pt) 2009-01-29
JP2007507431A (ja) 2007-03-29
CA2541813C (en) 2011-12-06
AU2004277290B2 (en) 2010-05-13
AU2004277290A1 (en) 2005-04-14
JP2012236855A (ja) 2012-12-06
DE602004017888D1 (de) 2009-01-02
JP2016185989A (ja) 2016-10-27
PL1677806T3 (pl) 2009-05-29
CN1859918B (zh) 2010-07-07
WO2005032562A1 (en) 2005-04-14
EP1677806A1 (en) 2006-07-12
SI1677806T1 (sl) 2009-06-30

Similar Documents

Publication Publication Date Title
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
NO20035743D0 (no) Substituerte oksazolindinoner for kombinasjonsterapi
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
EA201070740A1 (ru) Способ лечения перелома кости антителами против склеростина
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
EA200700214A1 (ru) Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией
MY150903A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
NZ517038A (en) Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
SE0400184D0 (sv) New therapeutical use
EP1348466A3 (en) Method for treating pain with adenosine-tetraphosphates
DE602004018944D1 (de) Verwendung von abführmittel zur behandlung des reizdarmsyndroms
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
BR0008443A (pt) Inibidores de aminotransferaseaminoácido-dependente de cadeia ramificada e seuuso no tratamento da retinopatia diabética
IS7912A (is) Notkun dókósahexensýru sem virks efnis til að meðhöndla fitukyrking
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
DK1251850T3 (da) Anvendelse af et kombinationspræparat i cancerbehandling
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
RU2010144554A (ru) Средство для предотвращения и/или лечения сосудистых заболеваний
NO20043774L (no) The use of devazenide as analgesic agent
JO2586B1 (en) Use of different sulfamide derivatives combined with benzo ring for pain management
BRPI0503488A (pt) agente de tratamento para sìndrome de intestino irritável com diarréia predominante